Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances and challenges of chimeric antigen receptor T cell therapy in digestive system malignancies. | World J Clin Oncol | 2026 | 41810338 | PubTator, text mining | PubMed |
| Recurrent Glioblastoma and the Tumor Immune Landscape: Emerging Immunotherapeutic Strategies. | Immunotargets Ther | 2026 | 41809120 | PubTator, text mining | PubMed |
| Efficacy and immunomodulatory effect of Claudin18.2-specific IL-7/XCL1 armored CAR-T cells in digestive tract cancer: preclinical and clinical analysis. | Signal Transduct Target Ther | 2026 | 41803093 | PubTator, text mining | PubMed |
| Preclinical advances and mechanistic insights of CAR-T therapy for acute myeloid leukemia: from target iteration to microenvironment regulation. | Ann Med | 2026 | 41800605 | PubTator, text mining | PubMed |
| Native chromatome profiling reveals hundreds of metabolic enzymes in the nucleus across tissues. | Nat Commun | 2026 | 41792114 | PubTator, text mining | PubMed |
| Development of immune-derived molecular markers for coronary heart disease via multimachine learning. | iScience | 2026 | 41782820 | PubTator, text mining | PubMed |
| CAR-T cell therapy for pediatric solid tumors: armored CAR-T cells and beyond. | Cancer Metastasis Rev | 2026 | 41770377 | PubTator, text mining | PubMed |
| Redefining the immune microenvironment of gliomas in the era of single-cell genomics. | Neurooncol Adv | 2026 | 41769417 | PubTator, text mining | PubMed |
| Beyond inflammation: metabolic implications of biological and TsDMARD therapies in dermatologic and rheumatologic diseases. | Front Immunol | 2026 | 41766878 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T cell therapy for glioblastoma: overcoming current barriers and strategies to enhance efficacy for therapeutic implications. | Biochem Pharmacol | 2026 | 41765112 | PubTator, text mining | PubMed |
| United Airway Disease: An Evolving Concept? A Scoping Review of the Modern Literature on Integrated Treatment Approaches. | Life (Basel) | 2026 | 41752857 | PubTator, text mining | PubMed |
| Cytokines Associated with Activation of CD4+CD25+Foxp3+ T Regulatory Cells. | Int J Mol Sci | 2026 | 41752221 | PubTator, text mining | PubMed |
| The Role of CRISPR and Its Therapeutic Applications in Glioblastoma. | Int J Mol Sci | 2026 | 41752145 | PubTator, text mining | PubMed |
| Challenges and Opportunities in Lentivirus Viral Vector Manufacturing for In Vivo Applications. | Biomedicines | 2026 | 41751268 | PubTator, text mining | PubMed |
| AGE-RAGE Axis Involvement in Allergies and Autoimmunity: Cellular Signaling, Barrier Dysfunction and Immune Polarization. | Biomolecules | 2026 | 41750311 | PubTator, text mining | PubMed |
| Progress of Research on the Metabolic Regulation of Lactylation in Muscle Tissues and Its Disease Associations. | Biomolecules | 2026 | 41750282 | PubTator, text mining | PubMed |
| GSCs in the Transdifferentiation Phenomenon: Focus on CAR-T-Based Therapy. | Cells | 2026 | 41744806 | PubTator, text mining | PubMed |
| Ready or not, here they come: a practical guide to adoptive T-cell therapies for solid tumors for medical oncologists. | Oncologist | 2026 | 41739670 | PubTator, text mining | PubMed |
| Chimeric antigen receptor macrophages therapy for glioblastoma: challenges and opportunities from preclinical evidence to clinical translation. | Front Immunol | 2026 | 41737231 | PubTator, text mining | PubMed |
| CAR-T Cell Therapy in Glioblastoma: Overcoming Immunological Barriers and Advancing Clinical Translation. | Cancer Manag Res | 2026 | 41737136 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=3